Home > Browse Research > Life Sciences > Diagnostics > In Vitro Diagnostics > Molecular Assays

Molecular Assays: market research reports

The field of molecular assays, molecular testing or molecular diagnostics is one that has shown promise as a renewing instrument of technological progress in the clinical laboratory and improved patient care in medicine. While the term “molecular diagnostics,” in its broadest sense, can be applied to clinical chemistry or immunoassay with equal validity—both technologies analyze molecular species—it has been reserved for use with technology and techniques that identify and/or quantitate genetic materials (DNA, RNA).

A better nomenclature might be “nucleic acid diagnostics” or “genetic diagnostics.” Indeed, in some instances, “nucleic acid diagnostics” has been used to refer to this technology. The term “molecular diagnostics,” however, has become the standard terminology that describes a technology dealing solely with the array of nucleotide sequences called gene and their expression and/or identifying presence in the determination of pathological states.

To many, molecular diagnostics offers an opportunity for the revival of what has been, for many years, a “less than stellar” diagnostics industry. Over the past 20 to 25 years, clinical diagnostics companies have presented the market with technology that has been little more than a reworking of older products and methods. A few substantive new tests have emerged over that period and alternative analytical technologies, such as bio- and chemiluminescent systems, have made key inroads in the clinical laboratory market. By and large, however, these have not been break-point technologies, that is, they have not revolutionized or replaced existing technology and converted markets.

Molecular Assays market research reports and industry analysis

Global Molecular Diagnostics Market 2012-2016 5/3/2013 \| published by: Infiniti Research Limited ... growth is the increasing investments in genomics and proteomics research. The Global Molecular Diagnostics market has also been witnessing a growth in the diagnostics segment. However, the compliance with regulatory requirements could pose a challenge ... \| read more...	$2,500.00
U.S. qPCR Reagents Market 4/4/2013 \| published by: Frost & Sullivan ... pricing pressure. This research service offers a discussion of the key market drivers and restraints, a detailed analysis of the changing competitive landscape, revenue forecasts, and the important trends affecting growth. Further discussed are selected ... \| read more...	$6,000.00
Histone Methyltransferases: Global Markets for Research Tools, Diagnostics and Drug Discovery 3/1/2013 \| published by: BCC Research ... data for 2012, estimates for 2013, and projections of compound annual growth rates (CAGRs) through 2018 Discussion of the history of epigenetics, descriptions of main epigenetic enzymes, targets for HMTs, the importance of HMTs in ... \| read more...	$5,450.00
Molecular Diagnostics 11/1/2012 \| published by: Global Industry Analysts ... Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2010 through 2018. A six-year historic analysis is also provided for these markets. The report profiles 103 companies including many ... \| read more...	$4,950.00
Labeling and Linking Agents for Immunoassays and Gene Probes 10/1/2011 \| published by: BCC Research ... of compound annual growth rates (CAGRs) through 2016 The most current and reliable information on consumption of probes and related chemicals in enzyme immunoassay Estimates of the global supply-and-demand scenario broken down by applications and ... \| read more...	$5,450.00
Global Molecular Diagnostics Market & Future Forecast 2010 - 2014 7/7/2011 \| published by: Renub Research ... diagnostics are also giving the market a big push. The increase in the aging population and incidences of various chronic diseases are driving the demand of molecular diagnostics world over. The industry is getting a ... \| read more...	$1,200.00
Molecular Diagnostics Markets 7/1/2011 \| published by: TriMark Publications ... diagnosis of patients, and the optimization of drug therapy. In the past few years, this rapidly evolving field has seen several fascinating developments. This TriMark Publications report describes the specific market segment of the in ... \| read more...	$3,400.00
Molecular Diagnostics Market Report: 2011 Edition 6/1/2011 \| published by: Koncept Analytics ... of the body. Primarily, the molecular diagnostic tests are performed for three purposes: diagnosis of the infectious diseases, genetic identification and the diagnosis of genetic diseases. Currently, molecular diagnostics represent a small share in the ... \| read more...	$800.00
Molecular Diagnostics: Market Segmentation and Opportunities 5/19/2011 \| published by: DeciBio ... (e.g., Her-2 overexpression in breast cancer). In recent years, MDx has experienced fast growth, given these tests high sensitivity, fast turnaround times and relatively low-cost compared to culture-based or immune-based techniques. MDx involves platforms and ... \| read more...	$1,800.00
Cell-based Assays: Technologies and Global Markets 5/1/2011 \| published by: BCC Research ... 2010, and projections of compound annual growth rates (CAGRs) through 2015 A breakdown of technology platforms at the forefront of cell-based assays, including flow cytometry, microscopy and image-based, laser capture microdissection and tissue microarrays, in ... \| read more...	$5,450.00
Cell-Based Assays 4/1/2011 \| published by: Global Industry Analysts ... comprehensive analytics for the US, Japan, Europe, and Rest of World. Annual estimates and forecasts are provided for the period 2009 through 2017. Also, a six-year historic analysis is provided for these markets. The report ... \| read more...	$4,200.00
Cell-Based Assays: World Market Prospects 2011-2026 1/19/2011 \| published by: Visiongain ... market data for 2009 to 2026. There, you will discover commercial prospects for cell assays in drug research, analyses found only in our report. You can benefit by ordering now, staying ahead. Our report shows ... \| read more...	$2,416.00
Companion Diagnostics: Technologies and Global Markets 11/1/2010 \| published by: BCC Research ... Valued at $170 million in 2010, analysts believe that by 2015, Oncotype Dx for breast cancer risk recurrence and drug regimen may reach $300 million, a compound annual growth rate (CAGR) of 12%. The approval ... \| read more...	$5,450.00
Personalized Medicine 2010: Assessing the Opportunities and Challenges in Commercializing Companion Diagnostics and Targeted Therapies 5/1/2010 \| published by: Arrowhead Publishers ... this paradigm promise to improve an individual’s treatment outcome and reduce healthcare expenditure, personalized medicine is set to transform the pharmaceutical/biotechnology and companion diagnostic markets. Arrowhead’s Personalized Medicine 2010 report provides an in-depth assessment of ... \| read more...	$2,495.00
Snapshots Denmark Fragrances 2009 3/16/2010 \| published by: Mintel - Snapshots ... covers female and male fragnances. Market value is based on sales. The data is supplied in both graphical and tabular format for ease of interpretation and analysis. The Snapshots Denmark Fragrances 2009 forms part of ... \| read more...	$600.00
Global Invitro Diagnostics Market 2009-2013 2/24/2010 \| published by: Infiniti Research Limited ... of these diagnostics tests has eliminated the need for certain cumbersome traditional diagnostic procedures. Moreover, health awareness among people has increased with the availability of better medical and health information. Moreover, the expectation for information ... \| read more...	$1,500.00
The Clinical Laboratory Services Market (Growth Opportunities, Competitive Analysis and Competitor Profiles) 2/1/2010 \| published by: Kalorama Information ... healthcare utilization in favor of the laboratory, making it an ever more valuable part of the treatment plan. As hospital stays are shortened, contact between the physician and patient is reduced, which places a larger ... \| read more...	$2,500.00
Patent map and technology intelligence report. Sugars; Derivatives Thereof; Nucleosides; Nucleotides; Nucleic Acids 1/24/2010 \| published by: Intellectual Property Exchange ... replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium; Compounds containing non-saccharide radicals linked to saccharide radicals by a carbon-to-carbon bond; Compounds containing a hetero ring sharing at least ... \| read more...	$1,200.00
Multiplex Assays: Evolving Technologies, Applications and Future Directions 1/1/2010 \| published by: CHI Insight Pharma Reports ... single-analyte biomarkers. However, a number of multiplex biomarkers not directly associated with particular drugs are in use as approved or homebrew diagnostics, and these contribute in various ways to the broad field of translational medicine. ... \| read more...	$2,995.00
U.S. Companion Diagnostics Markets 12/29/2009 \| published by: Frost & Sullivan ... key analysis and findings pertaining to the market. In addition, industry challenges and strategies for growth are in depth for the U.S. companion diagnostics market. Key developing business models in the market are also discussed. \| read more...	$6,000.00
Europe In Vitro Diagnotics Investment Opportunities, Analysis and Forecasts to 2015 12/29/2009 \| published by: Global Markets Direct ... comprehensive coverage of market revenue, distribution and company share information; and the latest news, financial deals and pipeline products information of each of the key sub-segments of the in vitro diagnostics market in Europe Scope ... \| read more...	$2,500.00
Biochips for Life Science Research, Diagnostics and Drug R&D 8/1/2009 \| published by: Takeda Pacific ... research products and services involve technologies that scientists use to detect and analyze genetic, protein, or related material such as DNA, RNA, proteins, antibodies, stem cells, tissues, biomarkers and so on. This study takes into ... \| read more...	$2,495.00
Infectious Disease Diagnostic Markets 8/1/2009 \| published by: Kalorama Information ... on this market recently and will continue to in years to come. Kalorama Information has been observing diagnostic markets for over a decade and has assembled in this report, Infectious Disease Diagnostics , Kalorama Information ... \| read more...	$1,995.00
Nucleic Acid Amplification Life Science Dashboard™ Series 2 7/1/2009 \| published by: Percepta Associates, Inc. ... expression. The Nucleic Acid Amplification Dashboard was developed from responses to a 21-question survey by 485 scientists predominantly located in North America and Europe. This Dashboard reveals key market indicators for the nucleic acid amplification ... \| read more...	$3,850.00
Rapid Advances in HIV/AIDS Clinical Diagnostics (Technical Insights) 6/30/2009 \| published by: Frost & Sullivan This research service provides the latest trends in HIV molecular diagnostics and discusses the prospects of future developments in this segment. \| read more...	$6,500.00

< prev 1 2 3 next >